Beta-1 blocker use linked to higher mortality in immune checkpoint inhibitor patients
A retrospective study of 2,409 patients found that baseline beta-1 selective beta-blocker therapy was independently associated with higher all-cause mortality, ...
Tag: cardiovascular immune-related adverse events
POPULAR NEWS
-
Dirac buffer layers reshape topological terahertz laser cavities for power and robustness
-
Rapidly Calibratable Hip Capsule Model Quantifies Capsular Restraint After Hip Replacement
-
Thermal Activation Enhances Bentonite Copper Removal
-
Two Carcinogen-Resistant Mole-Rats, Two Very Different Immune Playbooks